.
BioEnterprise

Rodeo Therapeutics

Rodeo Therapeutics develops novel small molecule therapies for the treatment of inflammatory bowel disease and the promotion of blood cell reconstitution following bone marrow transplant.

Funding

Accelerator Corporation, AbbVie, Alexandria Venture Investments, Arch Venture Partners, Eli Lilly & Co., Johnson & Johnson Innovation – JJDC Inc., Watson Fund, L.P., WRF Capital, WuXi AppTec

Stage

Preclinical